GM3 synthase overexpression results in reduced cell motility and in caveolin-1 upregulation in human ovarian carcinoma cells

Glycobiology

Volumn 20, Issue 1, 2010, Pages 62-77

  Prinetti, Alessandro ^a   Aureli, Massimo ^a   Illuzzi, Giuditta ^a   Prioni, Simona ^a   Nocco, Valentina ^a   Scandroglio, Federica ^a   Gagliano, Nicoletta ^a   Tredici, Giovanni ^b   Rodriguez Menendez, Virginia ^b   Chigorno, Vanna ^a   Sonnino, Sandro ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Caveolin 1; Gangliosides; GM3 synthase; Motility; Ovarian cancer

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ALPHA SMOOTH MUSCLE ACTIN; CAVEOLIN 1; GANGLIOSIDE GM1; GANGLIOSIDE GM2; GANGLIOSIDE GM3; SIALYLTRANSFERASE;

ARTICLE; CARCINOMA CELL; CELL MOTILITY; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; OVARY CARCINOMA; PHOTOACTIVATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RADIOACTIVITY; UPREGULATION; WILD TYPE;

ACTINS; CARCINOMA; CAVEOLIN 1; CELL LINE, TUMOR; CELL MOVEMENT; DNA PRIMERS; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OVARIAN NEOPLASMS; SIALYLTRANSFERASES; SPHINGOLIPIDS; SRC-FAMILY KINASES;

EID: 70849114215     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwp143     Document Type: Article

References (73)

1. Acquotti D, Cantu L, Ragg E, Sonnino S. 1994. Geometrical and conformational properties of ganglioside GalNAc-GD1a, IV4Gal NAcIV3Neu5AcII3Neu5AcGgOse4Cer. Eur J Biochem. 225:271-288.
2. Alessandri G, De Cristan G, Ziche M, Cappa AP, Gullino PM. 1992. Growth and motility of microvascular endothelium are modulated by the relative concentration of gangliosides in the medium. J Cell Physiol. 151:23-28.
3. Alessandri G, Filippeschi S, Sinibaldi P, Mornet F, Passera P, Spreafico F, Cappa PM, Gullino PM. 1987. Influence of gangliosides on primary and metastatic neoplastic growth in human and murine cells. Cancer Res 47:4243-4247.
4. Anderson RG. 1998. The caveolae membrane system. Annu Rev Biochem. 67:199-225.
5. Aoki T, Nomura R, Fujimoto T. 1999. Tyrosine phosphorylation of caveolin-1 in the endothelium. Exp Cell Res. 253:629-636.
6. Appierto V, Cavadini E, Pergolizzi R, Cleris L, Lotan R, Canevari S, Formelli F. 2001. Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line. Br J Cancer. 84:1528-1534.
7. Bartlett GR. 1959. Phosphorus assay in column chromatography. J Biol Chem. 234:466-468.
8. Berselli P, Zava S, Sottocornola E,Milani S, Berra B, Colombo I. 2006. Human GM3 synthase: A new mRNA variant encodes an NH2-terminal extended form of the protein. Biochim Biophys Acta. 1759:348-358.
9. Boyle PJ, Ma R, Tuteja N, Banerjee S, Basu S. 2006. Apoptosis of human breast carcinoma cells in the presence of cis-platin and L-/D-PPMP: IV. Modulation of replication complexes and glycolipid: Glycosyltransferases. Glycoconj J. 23:175-187.
10. Bremer EG, Schlessinger J, Hakomori S. 1986. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor. J Biol Chem 261:2434-2440.
11. Chigorno V, Cardace G, Pitto M, Sonnino S, Ghidoni R, Tettamanti G. 1986. A radiometric assay for ganglioside sialidase applied to the determination of the enzyme subcellular location in cultured human fibroblasts. Anal Biochem. 153:283-294.
12. Chigorno V, Pitto M, Cardace G, Acquotti D, Kirschner Gn, Sonnino S, Ghidoni R, Tettamanti G. 1985. Association of gangliosides to fibroblasts in culture: A study performed with GM1 [14C]-labelled at the sialic acid acetyl group. Glycoconj J. V2:279-291.
13. Chigorno V, Valsecchi M, Acquotti D, Sonnino S, Tettamanti G. 1990. Formation of a cytosolic ganglioside-protein complex following administration of photoreactive ganglioside GM1 to human fibroblasts in culture. FEBS Lett. 263:329-331.
14. Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP. 1997. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem. 272:6525-6533.
15. De Cristan G, Morbidelli L, Alessandri G, Ziche M, Cappa AP, Gullino PM. 1990. Synergism between gangliosides and basic fibroblastic growth factor in favouring survival, growth, and motility of capillary endothelium. J Cell Physiol. 144:505-510.
16. Deng W, Li R, Ladisch S. 2000. Influence of cellular ganglioside depletion on tumor formation. J Natl Cancer Inst. 92:912-917.
17. Fernandes H, Cohen S, Bishayee S. 2001. Glycosylation-induced conformational modification positively regulates receptor-receptor association: A study with an aberrant epidermal growth factor receptor (EGFRvIII/DeltaEGFR) expressed in cancer cells. J Biol Chem. 276:5375-5383.
18. Gabella G. 1978. Inpocketings of the cell membrane (caveolae) in the rat myocardium. J Ultrastruct Res. 65:135-147.
19. Ghidoni R, Sonnino S, Tettamanti G, Wiegandt H, Zambotti V. 1976. On the structure of two new gangliosides from beef brain. J Neurochem. 27:511-515.
20. Hakomori S-i. 1996. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 56:5309-5318.
21. Hakomori S. 2002. Glycosylation defining cancer malignancy: New wine in an old bottle. Proc Natl Acad Sci USA. 99:10231-10233.
22. Hanai N, Nores GA, MacLeod C, Torres-Mendez CR, Hakomori S. 1988. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 and lyso-GM3 in tyrosine phosphorylation of the epidermal growth factor receptor. J Biol Chem. 263:10915-10921.
23. Head BP, Insel PA. 2007. Do caveolins regulate cells by actions outside of caveolae? Trends Cell Biol. 17:51-57.
24. Head BP, Patel HH, Roth DM, Murray F, Swaney JS, Niesman IR, Farquhar MG, Insel PA. 2006. Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenylyl cyclase signaling components. J Biol Chem. 281:26391-26399.
25. Hinrichs JW, Klappe K, Hummel I, Kok JW. 2004. ATP-binding cassette transporters are enriched in non-caveolar detergent-insoluble glycosphingolipid-enriched membrane domains (DIGs) in human multidrug-resistant cancer cells. J Biol Chem. 279:5734-5738.
26. Inokuchi J, Jimbo M, Kumamoto Y, Shimeno H, Nagamatsu A. 1993. Expression of ganglioside GM3 and H-2 antigens in clones with different metastatic and growth potentials isolated from Lewis lung carcinoma (3LL) cell line. Clin Exp Metastasis. 11:27-36.
27. IUPAC-IUBMB Joint Commission on Biochemical Nomenclature. 1998. Nomenclature of glycolipids. Carbohydr Res. 312:167-175.
28. Kakugawa Y, Wada T, Yamaguchi K, Yamanami H, Ouchi K, Sato I, Miyagi T. 2002. Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression. Proc Natl Acad Sci USA. 99:10718-10723.
29. Kawakami Y, Kawakami K, Steelant WF, Ono M, Baek RC, Handa K, Withers DA, Hakomori S. 2002. Tetraspanin CD9 is a "proteolipid," and its interaction with alpha 3 integrin in microdomain is promoted by GM3 ganglioside, leading to inhibition of laminin-5-dependent cell motility. J Biol Chem. 277:34349-34358.
30. Kawamura S, Ohyama C, Watanabe R, Satoh M, Saito S, Hoshi S, Gasa S, Orikasa S. 2001. Glycolipid composition in bladder tumor: A crucial role of GM3 ganglioside in tumor invasion. Int J Cancer. 94:343-347.
31. Ladisch S, Kitada S, Hays EF. 1987. Gangliosides shed by tumor cells enhance tumor formation in mice. J Clin Invest. 79:1879-1882.
32. Lajoie P, Partridge EA, Guay G, Goetz JG, Pawling J, Lagana A, Joshi B, Dennis JW, Nabi IR. 2007. Plasma membrane domain organization regulates EGFR signaling in tumor cells. J Cell Biol. 179:341-356.
33. Lee H, Volonte D, Galbiati F, Iyengar P, Lublin DM, Bregman DB, Wilson MT, Campos-Gonzalez R, Bouzahzah B, Pestell RG, et al. 2000. Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: Identification of a c-Src/ Cav-1/Grb7 signaling cassette. Mol Endocrinol. 14:1750-1775.
34. Li S, Seitz R, Lisanti MP. 1996. Phosphorylation of caveolin by src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo. J Biol Chem. 271:3863-3868.
35. Loberto N, Prioni S, Bettiga A, Chigorno V, Prinetti A, Sonnino S. 2005. The membrane environment of endogenous cellular prion protein in primary rat cerebellar neurons. J Neurochem. 95:771-783.
36. Loberto N, Prioni S, Prinetti A, Ottico E, Chigorno V, Karagogeos D, Sonnino S. 2003. The adhesion protein TAG-1 has a ganglioside environment in the sphingolipid-enriched membrane domains of neuronal cells in culture. J Neurochem. 85:224-233.
37. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the folin phenol reagent. J Biol Chem. 193:265-275.
38. Mastick CC, Brady MJ, Saltiel AR. 1995. Insulin stimulates the tyrosine phosphorylation of caveolin. J Cell Biol. 129:1523-1531.
39. Mauri L, Casellato R, Kirschner G, Sonnino S. 1999. A procedure for the preparation of GM3 ganglioside from GM1-lactone. Glycoconj J. 16:197-203.
40. Mauri L, Prioni S, Loberto N, Chigorno V, Prinetti A, Sonnino S. 2004. Synthesis of radioactive and photoactivable ganglioside derivatives for the study of ganglioside-protein interactions. Glycoconj J. 20:11-23.
41. Mehlen P, Rabizadeh S, Snipas SJ, Assa-Munt N, Salvesen GS, Bredesen DE. 1998. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature. 395:801-804.
42. Miljan EA, Meuillet EJ, Mania-Farnell B, George D, Yamamoto H, Simon HG, Bremer EG. 2002. Interaction of the extracellular domain of the epidermal growth factor receptor with gangliosides. J Biol Chem. 277:10108-10113.
43. Miotti S, Tomassetti A, Facetti I, Sanna E, Berno V, Canevari S. 2005. Simultaneous expression of caveolin-1 and E-cadherin in ovarian carcinoma cells stabilizes adherens junctions through inhibition of src-related kinases. Am J Pathol. 167:1411-1427.
44. Mitsuzuka K, Handa K, Satoh M, Arai Y, Hakomori S. 2005. A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9. J Biol Chem. 280:35545-35553.
45. Miura Y, Kainuma M, Jiang H, Velasco H, Vogt PK, Hakomori S. 2004. Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside). Proc Natl Acad Sci USA 101:16204-16209.
46. Noguchi M, Kabayama K, Uemura S, Kang BW, Saito M, Igarashi Y, Inokuchi J. 2006. Endogenously produced ganglioside GM3 endows etoposide and doxorubicin resistance by up-regulating Bcl-2 expression in 3LL Lewis lung carcinoma cells. Glycobiology. 16:641-650.
47. Noguchi M, Suzuki T, Kabayama K, Takahashi H, Chiba H, Shiratori M, Abe S, Watanabe A, Satoh M, Hasegawa T, et al. 2007. GM3 synthase gene is a novel biomarker for histological classification and drug sensitivity against epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer. Cancer Sci. 98:1625-1632.
48. Ono M, Handa K, Sonnino S, Withers DA, Nagai H, Hakomori S. 2001. GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: Coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy. Biochemistry. 40:6414-6421.
49. Peinado B, Latorre R, Vaquez-Auton JM, Poto A, Ramirez G, Lopez-Albors O, Moreno F, Gil F. 2004. Histochemical skeletal muscle fibre types in the sheep. Anat Histol Embryol. 33:236-243.
50. Prinetti A, Basso L, Appierto V, Villani MG, Valsecchi M, Loberto N, Prioni S, Chigorno V, Cavadini E, Formelli F, et al. 2003. Altered sphingolipid metabolism in N-(4-hydroxyphenyl)-retinamide-resistant A2780 human ovarian carcinoma cells. J Biol Chem. 278:5574-5583.
51. Prinetti A, Chigorno V, Tettamanti G, Sonnino S. 2000. Sphingolipid-enriched membrane domains from rat cerebellar granule cells differentiated in culture. A compositional study. J Biol Chem. 275:11658-11665.
52. Prinetti A, Prioni S, Loberto N, Aureli M, Chigorno V, Sonnino S. 2008. Regulation of tumor phenotypes by caveolin-1 and sphingolipid-controlled membrane signaling complexes. Biochim Biophys Acta. 1780:585-596.
53. Saqr HE, Pearl DK, Yates AJ. 1993. A review and predictive models of ganglioside uptake by biological membranes. J Neurochem. 61:395-411.
54. Satoh M, Ito A, Nojiri H, Handa K, Numahata K, Ohyama C, Saito S, Hoshi S, Hakomori S. 2001. Enhanced GM3 expression, associated with decreased invasiveness, is induced by brefeldin A in bladder cancer cells. Int J Oncol. 19:723-731.
55. Scandroglio F, Loberto N, Valsecchi M, Chigorno V, Prinetti A, Sonnino S. 2008. Thin layer chromatography of gangliosides. Glycoconj J. DOI: 10.1007/s10719-008-9145-5.
56. Sonnino S, Chigorno V, Acquotti D, Pitto M, Kirschner G, Tettamanti G. 1989. A photoreactive derivative of radiolabeled GM1 ganglioside: Preparation and use to establish the involvement of specific proteins in GM1 uptake by human fibroblasts in culture. Biochemistry. 28:77-84.
57. Sonnino S, Chigorno V, Valsecchi M, Pitto M, Tettamanti G. 1992. Specific ganglioside-cell protein interactions: A study performed with GM1 ganglioside derivative containing photoactivable azide and rat cerebellar granule cells in culture. Neurochem Int. 20:315-321.
58. Sonnino S, Prinetti A. 2009. Sphingolipids and membrane environments for caveolin. FEBS Lett. 583:597-606.
59. Svennerholm L. 1957. Quantitative estimation of sialic acids: II. A colorimetric resorcinol-hydrochloric acid method. Biochim Biophys Acta. 24:604-611.
60. Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2:442-454.
61. Todeschini AR, Dos Santos JN, Handa K, Hakomori S-i. 2007. Ganglioside GM2-tetraspanin CD82 complex inhibits Met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse. J Biol Chem. 282:8123-8133.
62. Todeschini AR, Dos Santos JN, Handa K, Hakomori SI. 2008. Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway. Proc Natl Acad Sci USA 105:1925-1930.
63. Uemura S, Kabayama K, Noguchi M, Igarashi Y, Inokuchi J. 2003. Sialylation and sulfation of lactosylceramide distinctly regulate anchorage-independent growth, apoptosis, and gene expression in 3LL Lewis lung carcinoma cells. Glycobiology. 13:207-216.
64. Valaperta R, Chigorno V, Basso L, Prinetti A, Bresciani R, Preti A, Miyagi T, Sonnino S. 2006. Plasma membrane production of ceramide from ganglioside GM3 in human fibroblasts. FASEB J. 20:1227-1229.
65. Wang X-Q, Sun P, Paller AS. 2002. Ganglioside induces caveolin-1 redistribution and interaction with the epidermal growth factor receptor. J Biol Chem. 277:47028-47034.
66. Wang XQ, Sun P, Paller AS. 2003. Ganglioside GM3 blocks the activation of epidermal growth factor receptor induced by integrin at specific tyrosine sites. J Biol Chem. 278:48770-48778.
67. Wang XQ, Yan Q, Sun P, Liu JW, Go L, McDaniel SM, Paller AS. 2007. Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside. Cancer Res. 67:9986-9995.
68. Wary KK, Mariotti A, Zurzolo C, Giancotti FG. 1998. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell. 94:625-634.
69. Watanabe R, Ohyama C, Aoki H, Takahashi T, Satoh M, Saito S, Hoshi S, Ishii A, Saito M, Arai Y. 2002. Ganglioside GM3 overexpression induces apoptosis and reduces malignant potential in murine bladder cancer. Cancer Res. 62:3850-3854.
70. Wiechen K, Diatchenko L, Agoulnik A, Scharff KM, Schober H, Arlt K, Zhumabayeva B, Siebert PD, Dietel M, Schafer R, et al. 2001. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol. 159:1635-1643.
71. Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J,Muller WJ,Chopra NG, Scherer PE, Pestell RG, Lisanti MP. 2004. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem. 279:51630-51646.
72. Yang J, Liu Y. 2001. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol. 159:1465-1475.
73. Ziche M, Morbidelli L, Alessandri G, Gullino PM. 1992. Angiogenesis can be stimulated or repressed in vivo by a change in GM3:GD3 ganglioside ratio. Lab Invest. 67:711-715.